Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine cancer
    • Vaginal cancer
    • Vulval cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Head and neck cancer

head-mm cancer-types/head-and-neck-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Diagnosis
Loading...

How is head and neck cancer diagnosed?

  • Printer-friendly version
  • A|A

You might have a number of tests to investigate your symptoms and confirm a diagnosis of head and neck cancer. The more complex tests may be best carried out in conjunction with a dedicated head and neck cancer service. These tests may include:

  • medical history and physical examination of the mouth, throat and neck
  • biopsy, where a small sample of tissue is removed to be examined under a microscope
  • imaging tests – for example, X-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI) or positron emission tomography (PET) scan
  • endoscopy, where a thin tube with a light on its end is inserted through the nose to look for abnormalities in the throat
  • laryngoscopy, where a thin tube with a light on its end is inserted through the mouth to look for abnormalities in the larynx
  • nasoscopy, where a thin tube with a light on its end is used to look inside the nose
  • exfoliative cytology, where cells are scraped from the lips, tongue, mouth or throat to be examined under a microscope
  • a blood test to check for markers for Epstein–Barr virus (which is a risk factor for nasopharyngeal and salivary gland cancers)
  • hearing tests.

Stages of head and neck cancer

If you are diagnosed with head and neck cancer, you might have more tests to determine the stage of the disease and whether the cancer has spread to other parts of the body. Knowing the stage of the disease helps your medical team plan the best treatment for you.

Most types of head and neck cancer (nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, lip and oral cavity, nasal cavity and paranasal sinus cancer) have 5 stages: 0 (carcinoma in situ), I, II, III and IV. The stage depends on the size of the tumour and which other tissues it has spread to. Unlike staging conventions for most other cancers, head and neck cancers can be staged as stage IV without spread to more distant parts of the body.

Salivary gland cancers are divided into 4 stages (I–IV), rather than 5.

No standard staging system is used for metastatic squamous neck cancer with occult primary.

  • Last Updated
  • References
  • Relevant Links
updated: 20 October 2020 - 3:32pm
  • National Cancer Institute (2013). Head and neck cancers.
  • National Cancer Institute (2014). Salivary gland cancer treatment (PDQ®), patient version.
  • American Cancer Society (2015). Salivary gland cancer.
  • National Cancer Institute (2014). Metastatic squamous neck cancer with occult primary treatment (PDQ®), patient version.
  • American Cancer Society (2015). Nasal cavity and paranasal sinus cancer.
  • American Cancer Society (2015). Nasopharyngeal cancer.
  • American Cancer Society (2015). Laryngeal and hypopharyngeal cancer.
  • American Cancer Society (2015). Oral cavity and oropharyngeal cancer.
  • National Cancer Institute (2015). Oropharyngeal cancer treatment (PDQ®), patient version.
  • National Cancer Institute (2015). Paranasal sinus and nasal cavity cancer treatment (PDQ®), patient version.
  • National Cancer Institute (2014). Nasopharyngeal cancer treatment (PDQ®), patient version.
  • National Cancer Institute (2015). Hypopharyngeal cancer treatment (PDQ®), patient version.
  • National Cancer Institute (2015). Lip and oral cavity cancer treatment (PDQ®), patient version.
  • National Cancer Institute (2015). Laryngeal cancer treatment (PDQ®), patient version.
Head and neck cancer care pathways
American Cancer Society, Laryngeal and hypopharyngeal cancer
American Cancer Society, Nasal cavity and paranasal sinus cancer
American Cancer Society, Nasopharyngeal cancer
American Cancer Society, Oral cavity and oropharyngeal cancer
American Cancer Society, Salivary gland cancer
National Cancer Institute (US), Head and neck cancers

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2022 - Cancer Australia